Has QuVa Pharma Inc had other FDA enforcement actions?

Yes. Argus HQ has recorded 4 total FDA actions tied to QuVa Pharma Inc: 0 warning letters, 1 recall, 0 approval records, and 3 Form 483 inspection citations.

What kind of FDA record is this?

This is an Argus HQ record of a FDA Recall, tagged high severity by Argus HQ. FDA published the underlying record on 2026-07-15; Argus observed and indexed it on 2026-07-23.

Where can I verify this record directly with FDA?

The verbatim FDA source record is the source of truth — Argus HQ links directly to it below. Always confirm against fda.gov before acting.

.hq

fda_recall · drug_recall · high

QuVa Pharma, Inc. — Class II recall: Methohexital Sodium, 100 mg/10 mL (10 mg/mL), Total Volume: 10 mL, Rx only, Comp…

Name: FDA Recall Record — QuVa Pharma Inc
Creator: Argus HQ
Published: 2026-07-15
License: https://argushq.ai/methodology

Event date: 2026-07-15 00:00:00Z
Observed: 2026-07-23 04:20:34Z
Source ID: D-0664-2026
Payload hash: f2a4d3ae86e0b05842a13e36…

Summary

Failed Impurities/Degradation Specifications Status: Ongoing.

Entities

QuVa Pharma Inc

View source record ↗

Frequently asked questions

Has QuVa Pharma Inc had other FDA enforcement actions?: Yes. Argus HQ has recorded 4 total FDA actions tied to QuVa Pharma Inc: 0 warning letters, 1 recall, 0 approval records, and 3 Form 483 inspection citations.
What kind of FDA record is this?: This is an Argus HQ record of a FDA Recall, tagged high severity by Argus HQ. FDA published the underlying record on 2026-07-15; Argus observed and indexed it on 2026-07-23.
Where can I verify this record directly with FDA?: The verbatim FDA source record is the source of truth — Argus HQ links directly to it below. Always confirm against fda.gov before acting.

Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder

Cite this record

Reusing this data in reporting or research? Here’s a ready-made citation.

APA

Argus HQ Research (2026). QuVa Pharma, Inc. — Class II recall: Methohexital Sodium, 100 mg/10 mL (10 mg/mL), Total Volume: 10 mL, Rx only, Comp…. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/events/fda-recall-quva-pharma-inc-d-0664-2026

MLA

"QuVa Pharma, Inc. — Class II recall: Methohexital Sodium, 100 mg/10 mL (10 mg/mL), Total Volume: 10 mL, Rx only, Comp…." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/events/fda-recall-quva-pharma-inc-d-0664-2026.

Chicago

Argus HQ Research. "QuVa Pharma, Inc. — Class II recall: Methohexital Sodium, 100 mg/10 mL (10 mg/mL), Total Volume: 10 mL, Rx only, Comp…." Digital Empire Holdings LLC. Accessed July 23, 2026. https://argushq.ai/events/fda-recall-quva-pharma-inc-d-0664-2026.

BibTeX

@misc{argushq_argushq_ai_events_fda_recall_quva_pharma_inc_d_0664_2026_2026,
  title = {QuVa Pharma, Inc. — Class II recall: Methohexital Sodium, 100 mg/10 mL (10 mg/mL), Total Volume: 10 mL, Rx only, Comp…},
  author = {{Argus HQ Research}},
  year = {2026},
  publisher = {Digital Empire Holdings LLC},
  url = {https://argushq.ai/events/fda-recall-quva-pharma-inc-d-0664-2026},
  note = {Accessed: July 23, 2026}
}

Informational only. Not legal, financial, or medical advice.